Abstract
The fraction of nitric oxide in exhaled air (FeNO) is used in asthma diagnosis and management. Smoking reduces FeNO and 20-35% of asthmatics are smoking. However no guidelines exist on the diagnostic value of FeNO in smokers. Therefore we assessed the value of FeNO to diagnose asthma in a population of subjects with asthma-like symptoms and different smoking habits.
| Original language | English |
|---|---|
| Journal | Respiratory medicine |
| Volume | 106 |
| Issue number | 6 |
| Pages (from-to) | 794-801 |
| Number of pages | 8 |
| ISSN | 0954-6111 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Adolescent
- Adult
- Asthma
- Biological Markers
- Breath Tests
- Bronchial Hyperreactivity
- Diagnosis, Differential
- Eosinophils
- Female
- Forced Expiratory Volume
- Humans
- Hypersensitivity, Immediate
- Leukocyte Count
- Male
- Nitric Oxide
- Smoking
- Smoking Cessation
- Vital Capacity
- Young Adult
Fingerprint
Dive into the research topics of 'The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS